Abstract
This report analyzes the worldwide markets for Automated and Rapid
Microbiological Tests in Millions of US$. The Major End-Use Segments Analyzed
are Clinical Applications (Automated Identification & Susceptibility Systems,
Automated Blood Culture Systems, Automated Tuberculosis Systems, Streptococcal
Infection Rapid Tests, GC/Chlamydia Rapid Tests, & Other Automated & Rapid
Microbiological Tests), and Non-Clinical Applications. The report provides
separate comprehensive analytics for the US, Europe, and Rest of World. Annual
forecasts are provided for each region for the period of 2000 through 2015.
The report profiles 128 companies including many key and niche players
worldwide such as Abbott Laboratories, Abbott Diagnostics, Becton Dickinson
and Company, bioMerieux, bioMerieux, Inc., Bio-Rad Laboratories, Cellabs Pty
Ltd, Celsis International Plc., Coris BioConcept, F. Hoffmann-La Roche Ltd.,
Gen-Probe Incorporated, Genzyme Diagnostics, Inverness Medical Innovations,
Inc., Unipath Limited, MedMira Inc., Meridian Biosciences, Inc., Orasure
Technologies, Inc., Orion Diagnostica Oy, Quidel Corporation, Siemens Medical
Solutions Diagnostics, Thermo Fisher Scientific, Inc., Remel, Inc., and Oxoid
Limited. Market data and analytics are derived from primary and secondary
research. Company profiles are mostly extracted from URL research and reported
select online sources.
View Cart
